Tokyo, March 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060988) titled 'A Patient and Family Questionnaire Survey on Satisfaction with Lecanemab Treatment and Its Related Factors' on March 20.
Study Type:
Observational
Primary Sponsor:
Institute - Eisai Co., Ltd.
Condition:
Condition - Early Alzheimer's Disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate subjective satisfaction with lecanemab treatment among patients with early Alzheimer's disease and their family care partners in real-world clinical practice, and to identify factors influencing treatment satisfaction.
Basic objectives2 - Others
Eligibility:
Age-...